Explore

Trendline Trendline
Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Obesity Drug LET003

Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Obesity Drug LET003

Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Obesity Drug LET003
Trendline Trendline
ImmunityBio Secures Exclusive U.S. Rights to Tokyo Strain of BCG to Address Bladder Cancer Treatment Shortage

ImmunityBio Secures Exclusive U.S. Rights to Tokyo Strain of BCG to Address Bladder Cancer Treatment Shortage

ImmunityBio Secures Exclusive U.S. Rights to Tokyo Strain of BCG to Address Bladder Cancer Treatment Shortage
Trendline Trendline
Affinia Therapeutics Unveils Promising AFTX-201 Data for BAG3-Associated Cardiomyopathy at ASGCT Meeting

Affinia Therapeutics Unveils Promising AFTX-201 Data for BAG3-Associated Cardiomyopathy at ASGCT Meeting

Affinia Therapeutics Unveils Promising AFTX-201 Data for BAG3-Associated Cardiomyopathy at ASGCT Meeting
Trendline Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Affinia Therapeutics Advances Gene Therapy for BAG3-Associated Dilated Cardiomyopathy

Affinia Therapeutics Advances Gene Therapy for BAG3-Associated Dilated Cardiomyopathy

Affinia Therapeutics Advances Gene Therapy for BAG3-Associated Dilated Cardiomyopathy
Trendline Trendline
Biogen's Alzheimer's Results Support Tau Theory, Boosting Denali's Prospects

Biogen's Alzheimer's Results Support Tau Theory, Boosting Denali's Prospects

Biogen's Alzheimer's Results Support Tau Theory, Boosting Denali's Prospects
Trendline Trendline
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements
Trendline Trendline
Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies for Neurodegenerative Diseases

Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies for Neurodegenerative Diseases

Kariya and NeuraLight Collaborate on Brain-Focused GLP-1 Therapies for Neurodegenerative Diseases
Trendline Trendline
Tempus and Bristol Myers Squibb Partner to Enhance Clinical Development in Oncology and Neuroscience

Tempus and Bristol Myers Squibb Partner to Enhance Clinical Development in Oncology and Neuroscience

Tempus and Bristol Myers Squibb Partner to Enhance Clinical Development in Oncology and Neuroscience
Trendline Trendline
FDA Halts Aardvark's Prader-Willi Drug Trials Over Cardiac Concerns

FDA Halts Aardvark's Prader-Willi Drug Trials Over Cardiac Concerns

FDA Halts Aardvark's Prader-Willi Drug Trials Over Cardiac Concerns
Trendline Trendline
NanoViricides Reports $1.99M Net Loss in Q3 FY2026 Amid Clinical Advancements

NanoViricides Reports $1.99M Net Loss in Q3 FY2026 Amid Clinical Advancements

NanoViricides Reports $1.99M Net Loss in Q3 FY2026 Amid Clinical Advancements
Trendline Trendline
Regenxbio's Duchenne Gene Therapy Shows Promise Amid Safety Concerns

Regenxbio's Duchenne Gene Therapy Shows Promise Amid Safety Concerns

Regenxbio's Duchenne Gene Therapy Shows Promise Amid Safety Concerns